These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 16113832)

  • 1. Effect of surface modified liposomes on the aggregation of platelets and tumor cells.
    Keil C; Zeisig R; Fichtner I
    Thromb Haemost; 2005 Aug; 94(2):404-11. PubMed ID: 16113832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Poly(ethylene glycol)-grafted liposomes with oligopeptide or oligosaccharide ligands appended to the termini of the polymer chains.
    Zalipsky S; Mullah N; Harding JA; Gittelman J; Guo L; DeFrees SA
    Bioconjug Chem; 1997; 8(2):111-8. PubMed ID: 9095350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An aptamer ligand based liposomal nanocarrier system that targets tumor endothelial cells.
    Ara MN; Matsuda T; Hyodo M; Sakurai Y; Hatakeyama H; Ohga N; Hida K; Harashima H
    Biomaterials; 2014 Aug; 35(25):7110-20. PubMed ID: 24875764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the interaction of fluorophore-encapsulating PEGylated lecithin liposomes with hamster and human platelets.
    Heger M; Salles II; van Vuure W; Hamelers IH; de Kroon AI; Deckmyn H; Beek JF
    Microvasc Res; 2009 Jun; 78(1):57-66. PubMed ID: 19281828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disaccharide-modified liposomes and their in vitro intracellular uptake.
    Song CK; Jung SH; Kim DD; Jeong KS; Shin BC; Seong H
    Int J Pharm; 2009 Oct; 380(1-2):161-9. PubMed ID: 19635539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of sialyl Lewis X-glycoliposomes on the inhibition of E-selectin-mediated tumour cell adhesion in vitro.
    Zeisig R; Stahn R; Wenzel K; Behrens D; Fichtner I
    Biochim Biophys Acta; 2004 Jan; 1660(1-2):31-40. PubMed ID: 14757218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comprehensive study of iRGD-modified liposomes with improved chemotherapeutic efficacy on B16 melanoma.
    Dai W; Fan Y; Zhang H; Wang X; Zhang Q; Wang X
    Drug Deliv; 2015 Jan; 22(1):10-20. PubMed ID: 24735248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct comparison of liposomal doxorubicin with or without polyethylene glycol coating in C-26 tumor-bearing mice: is surface coating with polyethylene glycol beneficial?
    Hong RL; Huang CJ; Tseng YL; Pang VF; Chen ST; Liu JJ; Chang FH
    Clin Cancer Res; 1999 Nov; 5(11):3645-52. PubMed ID: 10589782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cationic poly(ethyleneglycol) lipids incorporated into pre-formed vesicles enhance binding and uptake to BHK cells.
    Fenske DB; Palmer LR; Chen T; Wong KF; Cullis PR
    Biochim Biophys Acta; 2001 Jun; 1512(2):259-72. PubMed ID: 11406103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RGD-modified liposomes targeted to activated platelets as a potential vascular drug delivery system.
    Gupta AS; Huang G; Lestini BJ; Sagnella S; Kottke-Marchant K; Marchant RE
    Thromb Haemost; 2005 Jan; 93(1):106-14. PubMed ID: 15630499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelets and PEGylated lecithin liposomes: when stealth is allegedly picked up on the radar (and eaten).
    Heger M; Salles II; de Kroon AI; Deckmyn H
    Microvasc Res; 2009 Jun; 78(1):1-3. PubMed ID: 19306888
    [No Abstract]   [Full Text] [Related]  

  • 12. Chloride channel-mediated brain glioma targeting of chlorotoxin-modified doxorubicine-loaded liposomes.
    Xiang Y; Liang L; Wang X; Wang J; Zhang X; Zhang Q
    J Control Release; 2011 Jun; 152(3):402-10. PubMed ID: 21435361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heteromultivalent liposomal nanoconstructs for enhanced targeting and shear-stable binding to active platelets for site-selective vascular drug delivery.
    Modery CL; Ravikumar M; Wong TL; Dzuricky MJ; Durongkaveroj N; Sen Gupta A
    Biomaterials; 2011 Dec; 32(35):9504-14. PubMed ID: 21906806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surface-Modification of RIPL Peptide-Conjugated Liposomes to Achieve Steric Stabilization and pH Sensitivity.
    Kwon YH; Shin TH; Jang MH; Yoon HY; Kang MH; Kang MJ; Choi YW
    J Nanosci Nanotechnol; 2017 Feb; 17(2):1008-17. PubMed ID: 29671978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo fate of folate-targeted polyethylene-glycol liposomes in tumor-bearing mice.
    Gabizon A; Horowitz AT; Goren D; Tzemach D; Shmeeda H; Zalipsky S
    Clin Cancer Res; 2003 Dec; 9(17):6551-9. PubMed ID: 14695160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient delivery of payload into tumor cells in a controlled manner by TAT and thiolytic cleavable PEG co-modified liposomes.
    Kuai R; Yuan W; Qin Y; Chen H; Tang J; Yuan M; Zhang Z; He Q
    Mol Pharm; 2010 Oct; 7(5):1816-26. PubMed ID: 20701288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of the novel PEG-PE-based polymer for the reversible attachment of specific ligands to liposomes: synthesis and in vitro characterization.
    Biswas S; Dodwadkar NS; Sawant RR; Torchilin VP
    Bioconjug Chem; 2011 Oct; 22(10):2005-13. PubMed ID: 21870873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of polyglycerol (PG), instead of polyethylene glycol (PEG), prevents induction of the accelerated blood clearance phenomenon against long-circulating liposomes upon repeated administration.
    Abu Lila AS; Nawata K; Shimizu T; Ishida T; Kiwada H
    Int J Pharm; 2013 Nov; 456(1):235-42. PubMed ID: 23928149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and in vitro targeting of sterically stabilized liposomes modified with chimeric TNT-3 monoclonal antibody.
    Pan H; Niu GQ; Pan J; Lu WY
    Yao Xue Xue Bao; 2006 Jun; 41(6):506-12. PubMed ID: 16927823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of cationic liposome formulations designed to exhibit extended plasma residence times and tumor vasculature targeting properties.
    Ho EA; Ramsay E; Ginj M; Anantha M; Bregman I; Sy J; Woo J; Osooly-Talesh M; Yapp DT; Bally MB
    J Pharm Sci; 2010 Jun; 99(6):2839-53. PubMed ID: 20091826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.